Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Aasya Nasar"'
Publikováno v:
Progress in Transplantation. 33:175-181
Introduction Guidelines recommend the use of direct oral anticoagulation therapy over warfarin for the treatment of venous thromboembolism and atrial fibrillation. However, there is uncertainty and a lack of data supporting the safety and efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec0134927a6d7150be6df333ee8fd556
https://doi.org/10.1177/15269248231164173
https://doi.org/10.1177/15269248231164173
Autor:
Lauren Cherrier, Razelle Grimes, Rajat Walia, Kellie J Goodlet, Aasya Nasar, Michael D Nailor
Publikováno v:
American Journal of Health-System Pharmacy. 79:338-345
Disclaimer In an effort to expedite the publication of articles , AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::795e0e016a4265ecb31d427424ebd2a0
https://doi.org/10.1093/ajhp/zxab389
https://doi.org/10.1093/ajhp/zxab389
Autor:
Aasya Nasar, Lauren Cherrier, Michael D Nailor, Clover N Truong, Rajat Walia, Kellie J Goodlet
Publikováno v:
Clinical Infectious Diseases. 74:1966-1971
Background Lung transplant recipients residing in the endemic region are vulnerable to severe morbidity and mortality from Coccidioides. As infection risk persists beyond the first posttransplant year, investigations evaluating extended prophylaxis d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90824edf6a52c2d13ecfba0baff6c3c7
https://doi.org/10.1093/cid/ciab752
https://doi.org/10.1093/cid/ciab752
Publikováno v:
Transplant Immunology. 75:101703
De novo donor-specific antibodies (DSAs) increase the risk of chronic lung allograft dysfunction (CLAD) in lung transplant recipients (LTRs). Both carfilzomib (CFZ) and rituximab (RTX) lower the mean fluorescent intensity (MFI) of DSAs, but comparati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a3fcac67141a9b54dbc73e3a52f9571
https://doi.org/10.1016/j.trim.2022.101703
https://doi.org/10.1016/j.trim.2022.101703
Autor:
Kellie J Goodlet, Lauren Cherrier, Rajat Walia, Aasya Nasar, Michael D Nailor, Clover N Truong
Publikováno v:
Clinical Infectious Diseases. 74:1886-1887
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c56a11f187541b4045b27908679ce33
https://doi.org/10.1093/cid/ciab879
https://doi.org/10.1093/cid/ciab879
Publikováno v:
Transplant Infectious Disease. 23
Background Lung transplant recipients are at heightened risk for nocardiosis compared to other solid organ transplant recipients, with incidence rates as high as 9% and up to 30% associated mortality. No controlled studies assessing risk factors for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6cc43fe7ecee675ba7f6eef3af8b989
https://doi.org/10.1111/tid.13478
https://doi.org/10.1111/tid.13478
Publikováno v:
Multidisciplinary Respiratory Medicine
Background: Cytomegalovirus (CMV) infection is extremely common after lung transplant and can be associated with significant morbidity and mortality. Current practice suggests the use of 900 mg daily of valganciclovir for CMV prophylaxis, but there i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2e3d35fb0cfa5af26b9765a577f3b0e
https://pubmed.ncbi.nlm.nih.gov/33569173
https://pubmed.ncbi.nlm.nih.gov/33569173
Publikováno v:
American Journal of Transplantation. 18:3060-3064
Following a year of valganciclovir prophylaxis, a lung transplant recipient developed cytomegalovirus (CMV) infection that became resistant to ganciclovir, as confirmed by detection of UL97 kinase mutation M460V and a previously uncharacterized UL54
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6afc3595fbc0ccb7734afc38cccc589
https://doi.org/10.1111/ajt.15135
https://doi.org/10.1111/ajt.15135
Autor:
Clover N Truong, Michael D Nailor, Rajat Walia, Lauren Cherrier, Aasya Nasar, Kellie J Goodlet
Publikováno v:
Open Forum Infectious Diseases. 8:S581-S581
Background Previous studies suggested that 6-12 months of universal or targeted azole prophylaxis is effective in preventing coccidioidomycosis for various organ transplant recipients. However, limited reports have described outcomes with longer prop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6d4475e8f328ddc8fea79659a9c0f29
https://doi.org/10.1093/ofid/ofab466.1174
https://doi.org/10.1093/ofid/ofab466.1174
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S359
Purpose Guidelines recommend the use of direct oral anticoagulation (DOAC) therapy over warfarin for the treatment of venous thromboembolism and atrial fibrillation. However, there is uncertainty and lack of data supporting the safety and efficacy of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5159d2a90d527bbf0ae949a98030c511
https://doi.org/10.1016/j.healun.2021.01.1011
https://doi.org/10.1016/j.healun.2021.01.1011